Fig. 3From: Decreased expression of stomatin predicts poor prognosis in HER2-positive breast cancerKaplan-Meier method showing 5-year disease-free (distant metastases-free) survival curves of HER2-positive infiltrating ductal carcinoma of breast comparing patients of positive and negative stomatin staining. Significant reduction of proportion surviving was noted in patients of stomatin (−) (n = 30), compared with patients of stomatin (+) (n = 35). p = 0.016Back to article page